Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Free Report) shares dropped 5.8% on Monday . The company traded as low as $4.34 and last traded at $4.34. Approximately 170 shares were traded during mid-day trading, a decline of 93% from the average daily volume of 2,615 shares. The stock had previously closed at $4.60.
Mayne Pharma Group Stock Performance
The business’s 50 day moving average price is $3.31 and its 200-day moving average price is $3.05.
About Mayne Pharma Group
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: International Branded Products, and Portfolio Product Division.
See Also
- Five stocks we like better than Mayne Pharma Group
- The Risks of Owning Bonds
- How to Protect Your Portfolio When Inflation Is Rising
- Top Stocks Investing in 5G Technology
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- How to Choose Top Rated Stocks
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
-etf-logo-1200x675.jpg?v=20230301141913&h=45&w=95&zc=2){kind=logo}
